These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 30452608)

  • 21. In-hospital and midterm post-discharge complications of adults hospitalised with respiratory syncytial virus infection in France, 2017-2019: an observational study.
    Descamps A; Lenzi N; Galtier F; Lainé F; Lesieur Z; Vanhems P; Amour S; L'Honneur AS; Fidouh N; Foulongne V; Lagathu G; Duval X; Merle C; Lina B; Carrat F; Launay O; Loubet P;
    Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 34446468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and outcomes in adult patients hospitalized with influenza, respiratory syncytial virus and human metapneumovirus infections.
    Chen L; Han X; Bai L; Zhang J
    Expert Rev Anti Infect Ther; 2021 Jun; 19(6):787-796. PubMed ID: 33141622
    [No Abstract]   [Full Text] [Related]  

  • 23. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible?
    Walsh EE; Peterson DR; Falsey AR
    J Infect Dis; 2007 Apr; 195(7):1046-51. PubMed ID: 17330796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost of Hospitalization Associated With Respiratory Syncytial Virus Infection Versus Influenza Infection in Hospitalized Older Adults.
    Ackerson B; An J; Sy LS; Solano Z; Slezak J; Tseng HF
    J Infect Dis; 2020 Aug; 222(6):962-966. PubMed ID: 32300806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022/2023 in a large German primary care centre.
    Quarg C; Jörres RA; Engelhardt S; Alter P; Budweiser S
    Eur J Med Res; 2023 Dec; 28(1):568. PubMed ID: 38053110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom.
    Fleming DM; Taylor RJ; Lustig RL; Schuck-Paim C; Haguinet F; Webb DJ; Logie J; Matias G; Taylor S
    BMC Infect Dis; 2015 Oct; 15():443. PubMed ID: 26497750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and disease burden of respiratory syncytial virus infection among hospitalized adults.
    Yoon JG; Noh JY; Choi WS; Park JJ; Suh YB; Song JY; Cheong HJ; Kim WJ
    Sci Rep; 2020 Jul; 10(1):12106. PubMed ID: 32694533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus - RSV-NET, 12 States, July 2022-June 2023.
    Havers FP; Whitaker M; Melgar M; Chatwani B; Chai SJ; Alden NB; Meek J; Openo KP; Ryan PA; Kim S; Lynfield R; Shaw YP; Barney G; Tesini BL; Sutton M; Talbot HK; Olsen KP; Patton ME;
    MMWR Morb Mortal Wkly Rep; 2023 Oct; 72(40):1075-1082. PubMed ID: 37796742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics, complications, and mortality of respiratory syncytial virus compared with influenza infections in hospitalized adult patients in Thailand.
    Chuaychoo B; Rattanasaengloet K; Banlengchit R; Horthongkham N; Athipanyasilp N; Totanarungroj K; Muangman N
    Int J Infect Dis; 2021 Sep; 110():237-246. PubMed ID: 34303842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and Outcomes Among Adults Aged ≥60 Years Hospitalized with Laboratory-Confirmed Respiratory Syncytial Virus - RSV-NET, 12 States, July 2022-June 2023.
    Havers FP; Whitaker M; Melgar M; Chatwani B; Chai SJ; Alden NB; Meek J; Openo KP; Ryan PA; Kim S; Lynfield R; Shaw YP; Barney G; Tesini BL; Sutton M; Talbot HK; Olsen KP; Patton ME;
    Am J Transplant; 2023 Dec; 23(12):2000-2007. PubMed ID: 37863432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical Characteristics and Course of Infections by Influenza A- and Respiratory Syncytial Virus (RSV) in Hospitalized Adults].
    Ambrosch A; Klinger A; Luber D; Arp C; Lepiorz M; Schroll S; Klawonn F
    Dtsch Med Wochenschr; 2018 May; 143(9):e68-e75. PubMed ID: 29510433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden of primary influenza and respiratory syncytial virus pneumonia in hospitalised adults: insights from a 2-year multi-centre cohort study (2017-2018).
    Boattini M; Charrier L; Almeida A; Christaki E; Moreira Marques T; Tosatto V; Bianco G; Iannaccone M; Tsiolakkis G; Karagiannis C; Maikanti P; Cruz L; Antão D; Moreira MI; Cavallo R; Costa C
    Intern Med J; 2023 Mar; 53(3):404-408. PubMed ID: 34633761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Real-World Analysis of Patient Characteristics and Predictors of Hospitalization Among US Medicare Beneficiaries with Respiratory Syncytial Virus Infection.
    Wyffels V; Kariburyo F; Gavart S; Fleischhackl R; Yuce H
    Adv Ther; 2020 Mar; 37(3):1203-1217. PubMed ID: 32026380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In- and Out-of-hospital Mortality Associated with Seasonal and Pandemic Influenza and Respiratory Syncytial Virus in South Africa, 2009-2013.
    Cohen C; Walaza S; Treurnicht FK; McMorrow M; Madhi SA; McAnerney JM; Tempia S
    Clin Infect Dis; 2018 Jan; 66(1):95-103. PubMed ID: 29040527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and Outcomes of Young Children Hospitalized With Laboratory-confirmed Influenza or Respiratory Syncytial Virus in Ontario, Canada, 2009-2014.
    Buchan SA; Chung H; Karnauchow T; McNally JD; Campitelli MA; Gubbay JB; Katz K; McGeer AJ; Richardson DC; Richardson SE; Simor A; Smieja M; Zahariadis G; Tran D; Crowcroft NS; Rosella LC; Kwong JC
    Pediatr Infect Dis J; 2019 Apr; 38(4):362-369. PubMed ID: 30882725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease burden caused by respiratory syncytial virus compared with influenza among adults: a retrospective cohort study from Eastern Finland in 2017-2018.
    Hämäläinen A; Savinainen E; Hämäläinen S; Sivenius K; Kauppinen J; Koivula I; Patovirta RL
    BMJ Open; 2022 Dec; 12(12):e060805. PubMed ID: 36535718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Epidemiologic Characteristics of Hospitalized Patients with Laboratory-Confirmed Respiratory Syncytial Virus Infection in Eastern China between 2009 and 2013: A Retrospective Study.
    Cui D; Feng L; Chen Y; Lai S; Zhang Z; Yu F; Zheng S; Li Z; Yu H
    PLoS One; 2016; 11(11):e0165437. PubMed ID: 27802292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medically attended respiratory syncytial virus infections in adults aged ≥ 50 years: clinical characteristics and outcomes.
    Sundaram ME; Meece JK; Sifakis F; Gasser RA; Belongia EA
    Clin Infect Dis; 2014 Feb; 58(3):342-9. PubMed ID: 24265361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents.
    Meury S; Zeller S; Heininger U
    Eur J Pediatr; 2004 Jul; 163(7):359-63. PubMed ID: 15106003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibiotic utilization in hospitalized children under 2 years of age with influenza or respiratory syncytial virus infection - a comparative, retrospective analysis.
    Papan C; Willersinn M; Weiß C; Karremann M; Schroten H; Tenenbaum T
    BMC Infect Dis; 2020 Aug; 20(1):606. PubMed ID: 32807104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.